Galantamine in Alzheimer's Disease with Cerebrovascular Components and Probable Vascular Dementia

Completed

Phase N/A Results

Summary of Purpose

To investigate the effects of galantamine in patients diagnosed with Alzheimer's disease (AD) with cerebrovascular components and probable vascular dementia according to NINDS-AIREN.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Multi-center, randomized, double-blind trial of 537 patients.

Contacts

Not available